| ATC code N: Nervous system |
|---|
|
| ATCvet only |
|
| Other ATC codes |
ATC code N06 Psychoanaleptics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup N06 is part of the anatomical group N Nervous system.
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN06. ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
N06A Antidepressants
N06AA Non-selective monoamine reuptake inhibitors
- N06AA01 Desipramine
- N06AA02 Imipramine
- N06AA03 Imipramine oxide
- N06AA04 Clomipramine
- N06AA05 Opipramol
- N06AA06 Trimipramine
- N06AA07 Lofepramine
- N06AA08 Dibenzepin
- N06AA09 Amitriptyline
- N06AA10 Nortriptyline
- N06AA11 Protriptyline
- N06AA12 Doxepin
- N06AA13 Iprindole
- N06AA14 Melitracen
- N06AA15 Butriptyline
- N06AA16 Dosulepin
- N06AA17 Amoxapine
- N06AA18 Dimetacrine
- N06AA19 Amineptine
- N06AA21 Maprotiline
- N06AA23 Quinupramine
N06AB Selective serotonin reuptake inhibitors
- N06AB02 Zimelidine
- N06AB03 Fluoxetine
- N06AB04 Citalopram
- N06AB05 Paroxetine
- N06AB06 Sertraline
- N06AB07 Alaproclate
- N06AB08 Fluvoxamine
- N06AB09 Etoperidone
- N06AB10 Escitalopram
N06AF Monoamine oxidase inhibitors, non-selective
- N06AF01 Isocarboxazid
- N06AF02 Nialamide
- N06AF03 Phenelzine
- N06AF04 Tranylcypromine
- N06AF05 Iproniazide
- N06AF06 Iproclozide
N06AG Monoamine oxidase A inhibitors
- N06AG02 Moclobemide
- N06AG03 Toloxatone
N06AX Other antidepressants
- N06AX01 Oxitriptan
- N06AX02 Tryptophan
- N06AX03 Mianserin
- N06AX04 Nomifensine
- N06AX05 Trazodone
- N06AX06 Nefazodone
- N06AX07 Minaprine
- N06AX08 Bifemelane
- N06AX09 Viloxazine
- N06AX10 Oxaflozane
- N06AX11 Mirtazapine
- N06AX12 Bupropion
- N06AX13 Medifoxamine
- N06AX14 Tianeptine
- N06AX15 Pivagabine
- N06AX16 Venlafaxine
- N06AX17 Milnacipran
- N06AX18 Reboxetine
- N06AX19 Gepirone
- N06AX21 Duloxetine
- N06AX22 Agomelatine
- N06AX23 Desvenlafaxine
- N06AX24 Vilazodone
- N06AX25 Hyperici herba
- N06AX26 Vortioxetine
- N06AX27 Esketamine
- N06AX28 Levomilnacipran
- N06AX29 Brexanolone
- N06AX31 Zuranolone
- N06AX62 Bupropion and dextromethorphan
- QN06AX90 Selegiline
N06B Psychostimulants, agents used for ADHD and nootropics
N06BA Centrally acting sympathomimetics
- N06BA01 Amphetamine
- N06BA02 Dexamphetamine
- N06BA03 Dextromethamphetamine
- N06BA04 Methylphenidate
- N06BA05 Pemoline
- N06BA06 Fencamfamin
- N06BA07 Modafinil
- N06BA08 Fenozolone
- N06BA09 Atomoxetine
- N06BA10 Fenetylline
- N06BA11 Dexmethylphenidate
- N06BA12 Lisdexamfetamine
- N06BA13 Armodafinil
- N06BA14 Solriamfetol
- N06BA15 Dexmethylphenidate and serdexmethylphenidate
N06BC Xanthine derivatives
- N06BC01 Caffeine
- N06BC02 Propentofylline
N06BX Other psychostimulants and nootropics
- N06BX01 Meclofenoxate
- N06BX02 Pyritinol
- N06BX03 Piracetam
- N06BX04 Deanol
- N06BX05 Fipexide
- N06BX06 Citicoline
- N06BX07 Oxiracetam
- N06BX08 Pirisudanol
- N06BX09 Linopirdine
- N06BX10 Nizofenone
- N06BX11 Aniracetam
- N06BX12 Acetylcarnitine
- N06BX13 Idebenone
- N06BX14 Prolintane
- N06BX15 Pipradrol
- N06BX16 Pramiracetam
- N06BX17 Adrafinil
- N06BX18 Vinpocetine
- N06BX21 Temgicoluril
- N06BX22 Phenibut
N06C Psycholeptics and psychoanaleptics in combination
N06CA Antidepressants in combination with psycholeptics
- N06CA01 Amitriptyline and psycholeptics
- N06CA02 Melitracen and psycholeptics
- N06CA03 Fluoxetine and psycholeptics
N06CB Psychostimulants in combination with psycholeptics
N06D Anti-dementia drugs
N06DA Anticholinesterases
- N06DA01 Tacrine
- N06DA02 Donepezil
- N06DA03 Rivastigmine
- N06DA04 Galantamine
- N06DA05 Ipidacrine
- N06DA52 Donepezil and memantine
- N06DA53 Donepezil, memantine and Ginkgo folium
N06DX Other anti-dementia drugs
- N06DX01 Memantine
- N06DX02 Ginkgo folium
- N06DX03 Aducanumab
- N06DX04 Lecanemab
- N06DX05 Donanemab
- N06DX30 Combinations
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code N06". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QN06". WHO Collaborating Centre for Drug Statistics Methodology.
| Psychostimulants, agents used for ADHD, and nootropics (N06B) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| N06BA Centrally acting sympathomimetics | |||||||||
| N06BC Xanthine derivatives | |||||||||
| N06BX Other psychostimulants and nootropics | |||||||||
| |||||||||
| Psychoanaleptics: Anti-dementia agents (ATC code N06D and others) | |
|---|---|
| AChE inhibitor medications | |
| Other medications | |
| Experimental BACE inhibitors | |